PMID: 9537211Apr 16, 1998Paper

Ifosfamide in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck: a phase II Hoosier Oncology Group trial

American Journal of Clinical Oncology
A SandlerM Arquette

Abstract

The Hoosier Oncology Group conducted a trial evaluating ifosfamide in patients who had recurrent or metastatic squamous cell carcinoma of the head and neck. Patients must have received no prior chemotherapy for metastatic disease. If prior adjuvant chemotherapy was given, the last cycle must have been at least six months from time of recurrence. All patients were required to have a Karnofsky performance status of > or = 50. Twenty-four patients received treatment consisting of ifosfamide, 1.5 g/m2/day for 5 days, with cycles repeated every 3 weeks. Mesna, 300 mg/m2, was administered intravenously 15 minutes before ifosfamide and 4 and 8 hours after ifosfamide on days 1 through 5. Toxicity was predominantly hematologic, with grade 3--4 neutropenia seen in 13 patients resulting in 4 episodes of neutropenic fever. One partial response was seen in 23 evaluable patients for an overall response rate of 4.3% (95% confidence interval, 0, 12.7%). In conclusion, ifosfamide would appear to have limited single-agent activity in squamous cell carcinoma of the head and neck.

References

Aug 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A A ForastiereS K Williamson
Feb 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I J SuA L Cheng
Feb 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C JacobsL Schacter
Feb 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M BuesaA J Lacave
Jun 15, 1988·Journal of the National Cancer Institute·M Zalupski, L H Baker
Jan 21, 1993·The New England Journal of Medicine·E E VokesW K Hong
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·M MartínS Dominguez
Aug 1, 1996·American Journal of Clinical Oncology·M H HuberW K Hong
Jan 1, 1997·CA: a Cancer Journal for Clinicians·S L ParkerP A Wingo

❮ Previous
Next ❯

Citations

Jan 19, 2012·Current Treatment Options in Oncology·Katharine A R Price, Ezra E Cohen
Feb 10, 2021·Nature Medicine·Nisha B NagarshethChristian S Hinrichs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.